Prof. Dr. Deepak Khobragade | Pharmacology | Academic Excellence Award

Published on by Academic Excellence

Prof. Dr. Deepak Khobragade | Pharmacology | Academic Excellence Award

Datta Meghe Institute of Higher Education nd Research(DU) | India

Dr. Deepak S. Khobragade is a distinguished academician, administrator, and pharmaceutical professional with over two decades of experience spanning higher education and the pharmaceutical industry. He is currently serving as Professor and Dean (Academics) at Datta Meghe College of Pharmacy, a constituent college of Datta Meghe Institute of Higher Education and Research (DMIHER), Wardha, Maharashtra, where he plays a pivotal role in academic leadership, curriculum development, and institutional growth. Dr. Khobragade has extensive graduate and postgraduate teaching experience, coupled with strong expertise in pharmaceutics, pharmaceutical formulations, and regulatory affairs. His academic journey includes a Ph.D. in Pharmaceutics from R.T.M. Nagpur University, with a research focus on sustained-release drug delivery systems. He also holds an M.Pharm. and B.Pharm., along with additional qualifications in Bioethics and Psychology, reflecting his multidisciplinary approach to education and human development. Before transitioning fully into academia, Dr. Khobragade gained valuable industry exposure with reputed organizations such as Zydus Cadila and Micro Labs Ltd., where he worked in U.S. and European regulatory affairs, strengthening his practical and compliance-oriented perspective. His academic career includes leadership roles as Professor, Associate Professor, Head of Department, Principal, and Dean, demonstrating his strong administrative and strategic capabilities.

Citation Metrics (Scopus)

100
50
25
10
0

Citations
73

Documents
41

h-index
4

Citations

Documents

h-index


View Scopus Profile
  View Google Scholar Profile

Featured Publications

Molecular Docking in Drug Discovery
– Journal of Pharmaceutical Research International, 2021
Health Care Waste: Avoiding Hazards to Living and Non-Living Environment by Efficient Management
– Fortune Journal of Health Sciences, 2019
Development and Evaluation of a Hot-Melt Coating Technique for Enteric Coating
– Brazilian Journal of Pharmaceutical Sciences, 2012
Evaluation of Hot Melt Coating as a Taste Masking Tool
– Research Journal of Pharmaceutical Sciences, 2011
Multi-Model Confirmatory Evaluation of Anti-inflammatory, Analgesic and Antioxidant Activities of Putranjiva roxburghii
– 2013

Syed Suhaib Ahmed | Pharmacology | Young Scientist Award

Published on by Academic Excellence

Prof. Syed Suhaib Ahmed | Pharmacology | Young Scientist Award

Prof. Syed Suhaib Ahmed | Pharmacology | Yenepoya Universtiy | India

Dr. Syed Suhaib Ahmed, M.Pharm., Ph.D., is a dynamic academician and researcher specializing in pharmaceutics and nanomedicine. With a strong foundation in pharmacy, he has advanced his expertise through extensive teaching, research, and scholarly contributions. Currently serving as Assistant Professor at Yenepoya Pharmacy College & Research Centre, Mangalore, he also continues his impactful research journey initiated at JSS College of Pharmacy, Ooty. His Ph.D. project focused on the design and development of surface-conjugated solid lipid nanoparticles co-encapsulating a flavonoid and an anticancer drug for targeted colon cancer therapy. Dr. Ahmed has authored several national and international publications in reputed journals and presented his work at conferences and seminars. His innovative contributions to drug delivery systems, formulation development, and nanotechnology position him as a promising researcher in pharmacology. Recognized with fellowships and grants, Dr. Ahmed embodies academic excellence, research innovation, and a strong commitment to advancing pharmaceutical sciences.

Author Profiles

Orcid | Google Scholar

Education

Dr. Ahmed’s educational foundation reflects his dedication to pharmaceutical sciences. He completed his Bachelor of Pharmacy (B. Pharm.) in 2017 from Nalanda College of Pharmacy, Nalgonda, under JNTUH, securing a solid academic base. To advance his knowledge in drug formulation and delivery, he pursued M.Pharm. (Pharmaceutics) in 2019 at the same institution. His postgraduate research explored “Formulation and in vitro evaluation of doxophylline oral disintegrating tablets,” marking his early entry into formulation design. Driven by a passion for translational research, he enrolled for his Ph.D. (2022–2024) at JSS College of Pharmacy, Ooty, under JSS Academy of Higher Education & Research. His doctoral thesis centered on surface-conjugated solid lipid nanoparticles incorporating irinotecan and daidzein for colon cancer treatment, a study that combined advanced nanotechnology with oncology. This robust academic trajectory highlights his strong theoretical knowledge, practical research expertise, and innovation in pharmaceutics.

Experience

Dr. Ahmed has developed a rich blend of teaching and research experience that strengthens his academic profile. He began his career as a Lecturer at JSS College of Pharmacy, Ooty (Feb 2022 – July 2024), where he taught undergraduate and postgraduate pharmacy students while mentoring research projects. In September 2024, he joined Yenepoya Pharmacy College & Research Centre, Mangalore as an Assistant Professor, further expanding his teaching and mentoring contributions. Alongside academics, Dr. Ahmed has actively engaged in high-impact research, particularly in nanoparticle-based drug delivery systems. His doctoral project on colon-targeted lipid nanoparticles has provided novel insights into cancer therapeutics. Beyond teaching and research, he has attended 29+ conferences, delivered 9 presentations, and participated in 17 workshops, enhancing his professional network and exposure. His expertise in handling advanced instruments like DLS, DSC, XRD, and HPLC, combined with his strong teaching skills, showcases his versatility as both an educator and researcher.

Awards and Honors

Dr. Ahmed’s dedication to pharmaceutical research has been recognized through prestigious awards and fellowships. He was the recipient of the JSSAHER Fellowship, supporting his early-stage Ph.D. research on innovative nanoparticle drug delivery. Additionally, His academic excellence and contributions are further highlighted through multiple opportunities to present his work at national and international platforms. He has actively participated in over 29 conferences, 17 workshops, and 9 oral/poster presentations, gaining recognition for his innovative approaches in pharmaceutics. His scholarly publications in high-impact journals like the International Journal of Biological Macromolecules and Applied Organometallic Chemistry reflect his growing influence in the pharmacology community. These achievements stand as a testament to his perseverance, innovation, and leadership, positioning him as a rising figure in pharmaceutical sciences.

Research Focus

Dr. Ahmed’s research interests lie at the intersection of nanomedicine, targeted drug delivery, and formulation development. His Ph.D. research on solid lipid nanoparticles (SLNs) co-encapsulating irinotecan and daidzein represents a significant step forward in colon cancer therapy, addressing challenges of drug solubility, stability, and targeted delivery. By conjugating nanoparticles with hyaluronic acid and bovine serum albumin, he designed a system capable of actively targeting CD44 and SPARC receptors on colon epithelia, ensuring enhanced therapeutic efficacy. His research includes both in vitro assays on HT-29 colon cancer cells and in vivo studies in Wistar rats, demonstrating translational potential. Beyond oncology, he has contributed to fields like microneedle technology, nanoparticle synthesis, and orphan drug formulation challenges. He is also interested in QbD (Quality by Design) approaches, polymeric drug delivery systems, and risk assessment in pharmaceutical development. His work aims to bridge laboratory innovation with clinical applications, making a tangible impact in pharmacology.

Publications

  1. Oral delivery of SLNs decorated with hyaluronic acid and BSA: Novel colon cancer therapy – IJ of Biological Macromolecules, 2024.

  2. Green synthesis of BSA–silver nanoparticles with anticancer activity – Applied Organometallic Chemistry, 2024.

  3. Exploring multistage nanocarriers for colon cancer treatment – Journal of Research in Pharmacy, 2023.

  4. Challenges in developing generic orphan drugs: US & EU survey – Value in Health Regional Issues, 2023.

  5. Risk assessment in COVID-19 vaccine formulation and transfer – Vitae, 2022.

  6. Folic acid–tailored daidzein SLNs for cytotoxicity against colon cancer – IJ of Applied Pharmaceutics, 2024.

  7. Advancements in microneedle drug delivery systems – IJ of Applied Pharmaceutics, 2024.

  8. Molecular docking studies of benzylidene amino phenyl acetamides – IJ of Applied Pharmaceutics, 2024.

  9. Formulation & evaluation of doxophylline ODTs – Research Journal of Pharmacy and Technology, 2020.

  10. Pharmaceutical product life cycle challenges for generic approvals – Indian J of Pharmaceutical Education & Research, 2022.

Conclusion

Dr. Syed Suhaib Ahmed represents the new generation of pharmacology researchers, combining academic rigor with cutting-edge nanomedicine innovations. His scholarly contributions, teaching excellence, and impactful research on targeted cancer therapies demonstrate his potential to redefine future directions in pharmaceutical sciences. With strong recognition through fellowships, grants, and publications in reputed journals, he is poised to make lasting contributions to pharmacology and translational drug development.

Karthikeyan Kesavan | Pharmacology | Best Researcher Award

Published on by Academic Excellence

Assoc. Prof. Dr. Karthikeyan Kesavan | Pharmacology | Best Researcher Award

Assoc. Prof. Dr. Karthikeyan Kesavan | Pharmacology | Department of Pharmacy, Guru Ghasidas University | India

Dr. Karthikeyan Kesavan is an accomplished academic and researcher serving as an Associate Professor in the Department of Pharmacy at Guru Ghasidas Vishwavidyalaya, Bilaspur. With a Ph.D. in Pharmaceutics from IIT-BHU and postdoctoral research experience at the University of Iowa under the DBT-GETin Fellowship, he has established himself as an expert in nanopharmaceuticals and ocular drug delivery. His research integrates nanotechnology with pharmaceutics to design innovative formulations for treating complex ocular and infectious diseases. Dr. Kesavan has guided Ph.D. and postgraduate scholars, published extensively in high-impact journals, authored influential book chapters, and holds multiple patents in novel drug delivery technologies. His consultancy projects also extend expertise in nanoformulations of natural metabolites for managing ocular diseases. With an H-index of 16 and growing international collaborations, Dr. Kesavan continues to bridge cutting-edge research with practical healthcare applications, contributing significantly to the advancement of pharmacology and pharmaceutical sciences.

Author Profiles

Orcid | Google Scholar

Education 

Dr. Kesavan’s educational journey reflects excellence and dedication to pharmaceutical sciences. He earned his Bachelor of Pharmacy degree, which laid the foundation for his research interests, before pursuing a Master of Pharmacy (M. Pharm) in Pharmaceutics from Bharathidasan University. His academic passion led him to the prestigious Indian Institute of Technology (BHU), Varanasi, where he obtained his Ph.D. in Pharmaceutics, specializing in novel drug delivery systems. To further strengthen his expertise, he completed postdoctoral research at the University of Iowa, USA, under the distinguished DBT-GETin Fellowship, where he gained advanced experience in nanotechnology-based ocular drug delivery. This exposure enhanced his global outlook and scientific rigor, allowing him to integrate diverse approaches into his work. His education uniquely positioned him to contribute to both academic and industry-level pharmaceutical innovations. Today, his academic background continues to influence his impactful research in nanopharmaceuticals, ocular therapeutics, and gene delivery strategies.

Experience

Dr. Kesavan has more than a decade of experience in academia, research, and international collaboration. As an Associate Professor at Guru Ghasidas Vishwavidyalaya, he has played a pivotal role in advancing pharmaceutics education and research. His career includes mentoring doctoral and postgraduate students, designing advanced curricula, and fostering multidisciplinary projects. His consultancy experience extends to developing nanoformulations from medicinal plant metabolites for ocular disease management, bridging academia and applied science. Internationally, his postdoctoral research at the University of Iowa refined his expertise in nanocarrier-mediated gene therapy and non-viral delivery systems. Dr. Kesavan has completed projects funded by UGC, including innovative work on chitosan-coated cationic nanoemulsions for ocular delivery. His professional contributions encompass guiding clinical relevance, managing funded projects, publishing in SCI-indexed journals, authoring influential book chapters, and securing multiple patents. His diverse roles highlight his leadership in pharmacological innovation and his ability to translate research into practical applications.

Awards & Honors 

Throughout his career, Dr. Kesavan has earned significant recognition for his contributions to pharmaceutics and drug delivery research. His selection for the prestigious DBT-GETin Fellowship enabled him to conduct postdoctoral research at the University of Iowa, expanding his international collaborations. He has been awarded UGC-BSR startup grants for innovative work in ocular nanopharmaceuticals, particularly chitosan-coated cationic nanoemulsions. His impactful research has led to multiple patent awards, including recognition for hybrid hydrogel systems and IoT-based health monitoring devices, demonstrating his interdisciplinary innovation. Beyond patents, his publications in high-impact journals and contributions to specialized book chapters highlight his scientific leadership. His role in guiding research scholars and his consultancy services further showcase his dedication to advancing pharmaceutical sciences. These honors not only validate his scientific excellence but also underscore his commitment to pioneering new frontiers in pharmacology and translating research into therapeutic solutions.

Research Focus

Dr. Kesavan’s research focus lies at the intersection of nanotechnology and pharmacology, with a special emphasis on ocular drug delivery systems. His investigations aim to overcome biological barriers by developing innovative nanocarriers, such as nanoemulsions, micelles, and nanocapsules, for improved treatment of eye diseases like glaucoma, uveitis, bacterial keratitis, and fungal infections. His work also explores gene therapy approaches using non-viral vectors for safer and more effective management of ocular disorders. In addition, his patents reflect his expertise in designing mucoadhesive, biocompatible systems that enhance therapeutic efficacy while reducing side effects. Expanding beyond ocular pharmacology, he has also contributed to cancer therapy and infectious disease research through nanocarrier-based formulations. By integrating pharmaceutical sciences with biotechnology and engineering, Dr. Kesavan’s research demonstrates translational value, bridging laboratory discoveries with clinical applications. His focus continues to advance the field of nanopharmaceuticals, ensuring patient-centered, innovative, and sustainable therapeutic solutions.

Publications

    • Healing efficiency of nystatin-loaded chitosan-guar gum-based nanocapsules in experimental fungal keratitis.

    • Tear-Driven Phase Transition Microemulsion for Ocular Delivery of Dexamethasone in Uveitis.

    • Cationic microemulsion of voriconazole for fungal keratitis treatment: in vitro and in vivo evaluation.

    • TPGS-Chitosan Conjugated Mucoadhesive Micelles of Brinzolamide for Glaucoma Therapy.

    • Cationic Chitosan/Pectin Nanocapsules of Moxifloxacin for Bacterial Keratitis Management.

    • Cationic Polyelectrolyte Nanocapsules of Moxifloxacin for Microbial Keratitis Therapy.

    • Phase Transition Microemulsion of Brimonidine Tartrate for Glaucoma Therapy.

    • Brinzolamide loaded chitosan-pectin mucoadhesive nanocapsules for glaucoma therapy.

    • Positively Charged TPGS-Chitosan Nanocapsules as Non-Viral Vector for Glaucoma Gene Therapy.

    • Topical Ocular Delivery of Nanocarriers: A Feasible Choice for Glaucoma Management.

    • Ocular SMEDDS of Prednisolone for Improved Uveitis Therapy .

    • Tamoxifen citrate loaded chitosan-gellan nanocapsules for breast cancer therapy.

    • Phase Transition W/O Microemulsions for Antibacterial Activity in Bacterial Keratitis.

    • Chitosan-Coated Microemulsions for Enhanced Dermal Clotrimazole Delivery.

Conclusion

Dr. Karthikeyan Kesavan exemplifies excellence in pharmacology through his pioneering research in nanopharmaceuticals, ocular drug delivery, and innovative therapeutic approaches. With a strong educational foundation, impactful teaching experience, and international collaborations, he has established himself as a leader in pharmaceutical research. His extensive publications, patents, and consultancy work highlight his contributions to both academic and industrial advancements. Dr. Kesavan’s dedication to addressing unmet medical needs through nanotechnology-driven solutions continues to shape the future of pharmacology, making him a highly deserving candidate for recognition in the field.

Ines Feki | Pharmacology | Excellence in Research

Published on by Academic Excellence

Mrs. Ines Feki | Pharmacology | Excellence in Research

Mrs. Ines Feki, Institut supérieur de Biotehnologie de Sfax et laboratoire de bioprocédés Environnementaux Centre of Biotechnology of Sfax (CBS), université de Sfax, Tunisia

Dr. Ines Feki is a distinguished academic and researcher specializing in pharmacology, toxicology, and pharmaceutics. She is currently an Assistant Professor at the Higher Institute of Biotechnology of Sfax, University of Sfax, Tunisia. Dr. Feki completed her PhD in Biological Sciences in 2006 and has been an active contributor to academic research and teaching for over two decades. Her work focuses on environmental bioprocesses and medical biotechnology, contributing to advancements in public health. As a prolific author, she has published 20 international journal articles and holds a patent. Dr. Feki is also a member of multiple professional committees, mentoring undergraduate and postgraduate students. She collaborates with renowned institutions worldwide, including universities in Japan and Tunisia. Her dedication to research and education exemplifies her commitment to advancing pharmacological sciences for societal benefit.

Professional Profile

Scopus

Assessment of Dr. Ines Feki for the “Research for Excellence in Research” Award

Dr. Ines Feki, currently affiliated with the Laboratory of Environmental Bioprocesses, Centre of Biotechnology of Sfax, demonstrates a solid academic and professional background with a focus on biological sciences and biotechnology. Her educational qualifications, including a PhD in Biological Sciences and a Master’s degree in Biological Engineering, reflect a foundation of advanced expertise. Furthermore, her professional journey, spanning over two decades, includes roles as an Assistant Professor at two prestigious universities in Tunisia, emphasizing her long-standing dedication to research and teaching.

Dr. Feki’s research contributions are notable, with 20 international journal publications across reputed platforms, a published patent, and several completed research projects. These achievements highlight her innovative approach and dedication to advancing pharmacology, toxicology, and pharmaceutics. Notably, her active role in editorial appointments and collaborative projects with international and national institutions underscores her ability to foster meaningful academic and research partnerships.

🎓 Education 

Dr. Ines Feki has a robust educational background in biological sciences and engineering. She earned her PhD in Biological Sciences from the Faculty of Sciences of Sfax, University of Sfax, in 2006, focusing on advanced biotechnological processes. Prior to that, she completed her Master’s degree in Biological Engineering from the Engineering School of Sfax in 1998, where she gained foundational expertise in innovative engineering applications in life sciences. Dr. Feki’s academic journey began with a Bachelor’s degree in Natural Sciences from the Faculty of Sciences of Sfax, completed in 1996. Her educational foundation has equipped her with interdisciplinary knowledge, merging biological sciences and engineering to address challenges in pharmacology and bioprocesses. This strong academic background has fueled her innovative contributions to medical biotechnology and environmental research.

💼 Professional Experience

Dr. Ines Feki has accumulated extensive academic and research experience over her career. From 2005 to 2011, she served as an Assistant Professor at the Faculty of Sciences of Gafsa, University of Gafsa, where she mentored students and conducted pivotal research. Since 2011, she has been an Assistant Professor at the Higher Institute of Biotechnology of Sfax (ISBS), University of Sfax, actively involved in teaching and research on pharmacology and biotechnology. She has contributed as a member of the Master’s Committee in Medical Biotechnology since 2022 and has been part of jury committees for Bachelor’s and Professional Master’s degrees since 2012. Dr. Feki has also collaborated on various research projects with esteemed international institutions, further cementing her reputation as a global academic leader. Her dedication to education and mentorship reflects her passion for fostering the next generation of scientists.

🏅 Awards and Recognition 

Dr. Ines Feki’s exemplary contributions to research and academia have earned her numerous accolades. She has published 20 international journal articles, with five as the lead author, showcasing her expertise and leadership in pharmacology and medical biotechnology. Her innovative work has been recognized with a published patent, highlighting her contributions to advancing biotechnology. As a valued member of academic committees, she has significantly influenced curriculum development and evaluation in higher education. Dr. Feki’s collaborations with prestigious institutions in Japan and Tunisia underline her global impact and recognition as a thought leader. Her role in guiding students and professionals has further established her as an influential educator and mentor in the field. These achievements underscore her commitment to fostering innovation and academic excellence.

🌍 Research Skills On Pharmacology

Dr. Ines Feki is a skilled researcher with expertise in pharmacology, toxicology, and pharmaceutics. Her work bridges the gap between environmental bioprocesses and medical biotechnology. She has completed three research projects, published 20 international journal articles, and holds a patent, showcasing her innovative capabilities. Dr. Feki collaborates with global institutions such as the University of Tsukuba in Japan and national laboratories in Tunisia, focusing on interdisciplinary approaches to address health challenges. Her editorial contributions to multiple publications highlight her strong analytical and communication skills. Additionally, Dr. Feki has guided numerous students in Bachelor’s and Master’s programs, ensuring the practical application of her research. Her expertise extends to designing, conducting, and publishing impactful studies, making her a leader in pharmacological sciences. Dr. Feki’s dedication to research is evident in her ability to develop innovative solutions and her commitment to knowledge dissemination.

📖 Publication Top Notes

  • Hepatoprotective Effect of Oleuropein-Rich Extract from Olive Leaves against Cadmium-Induced Toxicity in Mice
    • Authors: Jemai, H.; Mahmoudi, A.; Feryeni, A.; Chamkha, M.; Sayadi, S.
    • Citations: 19
    • Year: 2020
  • Comparative Study on Beneficial Effects of Hydroxytyrosol- and Oleuropein-Rich Olive Leaf Extracts on High-Fat Diet-Induced Lipid Metabolism Disturbance and Liver Injury in Rats
    • Authors: Fki, I.; Sayadi, S.; Mahmoudi, A.; Marrekchi, R.; Ghorbel, H.
    • Citations: 82
    • Year: 2020
  • Oleuropein and Hydroxytyrosol Protect Rats’ Pups against Bisphenol A Induced Hypothyroidism
    • Authors: Mahmoudi, A.; Ghorbel, H.; Feki, I.; Ayadi, L.; Sayadi, S.
    • Citations: 15
    • Year: 2018
  • Oleuropein and Hydroxytyrosol Rich Extracts from Olive Leaves Attenuate Liver Injury and Lipid Metabolism Disturbance in Bisphenol A-Treated Rats
    • Authors: Mahmoudi, A.; Hadrich, F.; Feki, I.; Fourati, H.; Sayadi, S.
    • Citations: 57
    • Year: 2018
  • Olive Phenolic Compounds Attenuate Deltamethrin-Induced Liver and Kidney Toxicity through Regulating Oxidative Stress, Inflammation, and Apoptosis
    • Authors: Maalej, A.; Mahmoudi, A.; Bouallagui, Z.; Marrekchi, R.; Sayadi, S.
    • Citations: 64
    • Year: 2017
  • Emerging Technologies for Recovery of Value-Added Components from Olive Leaves and Their Applications in Food/Feed Industries
    • Authors: Souilem, S.; Fki, I.; Kobayashi, I.; Sayadi, S.; Nakajima, M.
    • Citations: 67
    • Year: 2017
  • Evaluation of Hypocholesterolemic Effect of Oleuropein in Cholesterol-Fed Rats
    • Authors: Hadrich, F.; Mahmoudi, A.; Bouallagui, Z.; Feve, B.; Sayadi, S.
    • Citations: 50
    • Year: 2016
  • Comparative Study on Phenolic Profile and Antioxidant Potential of Six Tunisian Autochthonous Olive Cultivars
    • Authors: Gargouri, B.; Feki, I.; Mansour, A.M.; Bouaziz, M.
    • Citations: 0
    • Year: 2013
  • Hypoglycemic and Antioxidant Effects of Leaf Essential Oil of Pelargonium graveolens L’Hér. in Alloxan-Induced Diabetic Rats
    • Authors: Boukhris, M.; Bouaziz, M.; Feki, I.; El Feki, A.; Sayadi, S.
    • Citations: 127
    • Year: 2012
  • Biochemical and Histological Liver Changes Occurred after Iron Supplementation and Possible Remediation by Garlic Consumption
    • Authors: Ghorbel, H.; Feki, I.; Friha, I.; Boudawara, M.; Sayadi, S.
    • Citations: 3
    • Year: 2011

Aruhan | Pharmacology | Best Researcher Award

Published on by Academic Excellence

Dr. Aruhan | Pharmacology | Best Researcher Award

👤  Dr. Aruhan, Jiangxi University of Chinese Medicine, China

Aruhan is a dedicated researcher and scholar at Jiangxi University of Chinese Medicine. Having completed his Bachelor’s and Master’s degrees at Inner Mongolia Minzu University, he is currently pursuing his Doctoral degree in the field of Pharmacology. Aruhan’s research primarily focuses on mental illness, particularly exploring innovative pharmacological solutions for treating mood disorders. His academic journey has been marked by consistent achievements, including multiple academic scholarships and prestigious awards, such as the “Outstanding Student” honor certificate. Aruhan’s work has contributed to the development of new insights into pharmacological treatments, and he continues to expand his academic and research portfolio. His ongoing commitment to understanding mental health and contributing to the scientific community is evident in his recent publication in the Journal of Ethnopharmacology, where he co-authored a study on the potential benefits of Syringa oblata Lindl Extract for alleviating depression.

Professional Profile

orcid

🌟 Suitability for the Research for Best Researcher Award

Aruhan is a promising candidate for the Research for Best Researcher Award due to his academic excellence and commitment to research in the field of mental illness. His educational journey, spanning from a Bachelor’s degree to his ongoing Doctoral studies at Jiangxi University of Chinese Medicine, reflects a consistent dedication to advancing his knowledge.

Though he has not completed ongoing research projects, his work on mental illness, specifically the publication in the Journal of Ethnopharmacology, demonstrates significant potential in the field. This research, titled Syringa oblata Lindl Extract Alleviated Corticosterone-Induced Depression via the cAMP/PKA–CREB–BDNF Pathway, indicates an understanding of complex biochemical pathways involved in depression and offers promising implications for future therapeutic approaches. His first publication is a strong demonstration of his capability, which will likely serve as a foundation for more impactful research in the future.

🎓 Education

Aruhan’s academic journey began with a Bachelor’s degree in Pharmacology from Inner Mongolia Minzu University, where he laid the foundation for his future research endeavors. After completing his undergraduate studies in 2018, he pursued a Master’s degree at the same institution, refining his research focus on pharmacology and mental health. During his Master’s program, Aruhan gained hands-on experience in laboratory research, delving into various pharmacological pathways associated with mental illnesses. This period allowed him to solidify his passion for drug discovery and mental health treatments. Since September 2022, Aruhan has been working towards his Doctoral degree at Jiangxi University of Chinese Medicine. His doctoral research focuses on unraveling the complex mechanisms of mental illness and evaluating the efficacy of medicinal plants. Alongside his academic work, he continues to contribute to the scientific community with several notable publications. Aruhan’s educational background is a testament to his strong commitment to advancing pharmacological research.

💼   Professional Experience

Although Aruhan is in the early stages of his professional career, his academic and research experiences are noteworthy. His work has primarily centered around the pharmacological treatment of mental illnesses. As a doctoral candidate at Jiangxi University of Chinese Medicine, he has contributed to a significant publication in the Journal of Ethnopharmacology on the antidepressant potential of Syringa oblata Lindl Extract. Despite his limited professional experience, Aruhan’s academic performance and involvement in research projects demonstrate his potential to make substantial contributions to the field of pharmacology. In addition to his research, he has actively participated in several academic forums, including the 2022 Conference on Industry-University-Research Cooperation, where he won the third prize for his presentation on the role of pharmacology in mental health. His academic journey is marked by consistent recognition and accolades, positioning him as a promising scholar in pharmacological research and development.

🏅Awards and Recognition 

Aruhan has earned numerous awards throughout his academic career, reflecting his dedication and excellence in his field. Notably, in November 2022, he won the third prize at the “Young Scholars Forum” during the 2022 Conference on Industry-University-Research Cooperation. He was also recognized with multiple academic scholarships, including the second-class general scholarship at Jiangxi University of Chinese Medicine in both 2022 and 2023. Additionally, Aruhan has consistently earned the “Outstanding Student” honor certificate for two consecutive academic years (2022-2023 and 2024-2025), further demonstrating his strong academic standing. His commitment to research excellence and academic achievements culminated in receiving the Lan Shu Excellent Scholarship in 2024. These awards not only reflect his scholastic achievements but also highlight his potential to make meaningful contributions to the field of pharmacology, particularly in mental health research. Aruhan’s passion for advancing science is mirrored in his continual pursuit of academic excellence.

🌍  Research Skills On Pharmacology

Aruhan’s research skills are diverse and robust, allowing him to effectively explore the complexities of mental health and pharmacology. His expertise lies in studying the pharmacological effects of medicinal plants, with a focus on their antidepressant properties. Aruhan is proficient in various research methodologies, including in vivo and in vitro techniques, which enable him to explore the biochemical and molecular mechanisms behind mental illnesses. He is adept at data collection and analysis, using advanced statistical methods to interpret complex research results. His strong laboratory skills are complemented by his ability to synthesize information from a range of academic resources, helping him draw meaningful conclusions in his work. Moreover, Aruhan demonstrates a keen understanding of drug-receptor interactions and the pharmacodynamics of therapeutic agents. His ability to collaborate and communicate findings effectively enhances his research, contributing to his growing reputation within the academic community. Aruhan is committed to continuous learning, ensuring that his research remains relevant and impactful.

📖 Publication Top Notes

Syringa oblata Lindl Extract Alleviated Corticosterone-Induced Depression via the cAMP/PKA–CREB–BDNF Pathway
  • Journal: Journal of Ethnopharmacology
  • Author(s): Ruhan A

Ms. Rui Gao | Pharmacology | Best Researcher Award

Published on by Academic Excellence

Ms. Rui Gao | Pharmacology | Best Researcher Award

👤   Ms. Rui Gao, Shandong First Medical University, China

Rui Gao, a dedicated scholar in Pharmacology and Clinical Pharmacy, is a Master’s student at Shandong First Medical University. Rui has demonstrated academic excellence throughout their educational journey, earning scholarships for two consecutive years during graduate studies. An active participant in practical and research activities, Rui presented an outstanding manuscript at the Clinical Pharmacy Section of the Chinese Medical Association, showcasing their commitment to advancing pharmaceutical science. With a focus on GLP-1 receptor agonists (GLP-1RAs) and their gastrointestinal effects, Rui has contributed to impactful research published in renowned journals like Frontiers in Endocrinology and Life Sciences. Rui’s innovative approach to pharmacological challenges emphasizes personalized medicine and optimization of clinical outcomes. Driven by a passion for research and a commitment to advancing pharmacological knowledge, Rui aspires to make lasting contributions to the field, bridging the gap between theoretical concepts and practical healthcare applications.

Professional Profile

scopus

🌟  Ms. Rui Gao, Summary of Suitability for the Research for Best Researcher Award

Rui Gao is a highly qualified candidate for the ‘Research for Best Researcher Award’ based on his excellent academic background and significant contributions to the field of pharmacology and clinical pharmacy. He has demonstrated outstanding academic performance, evidenced by his excellent undergraduate grades, active participation in practical activities, and consecutive scholarships during his graduate studies at Shandong First Medical University. His engagement with the Clinical Pharmacy Section of the Chinese Medical Association, particularly his submission that earned recognition as an outstanding manuscript, showcases his dedication to the advancement of his field.

🎓 Education 

Rui Gao’s academic foundation was laid at North Minzu University, where they excelled in their undergraduate studies, earning top grades and participating actively in practical initiatives. Their dedication was recognized with the Certificate of Competence in 3D Digitizing Technology (CAD), highlighting their technical acumen. Rui pursued graduate studies at Shandong First Medical University, achieving excellent academic performance and earning scholarships for two consecutive years. Their commitment to professional growth was evident through active involvement in research, including a recognized manuscript at the Clinical Pharmacy Section of the Chinese Medical Association. Rui’s education blends strong theoretical understanding with hands-on research expertise, fostering a unique capability to tackle complex challenges in pharmacology and clinical pharmacy. This solid academic background underpins Rui’s focus on GLP-1 receptor agonists and their clinical implications, setting a strong platform for a thriving career in medical science and pharmacological research.

💼 Professional Experience 

Rui Gao’s professional experience is deeply rooted in academic research and innovation. As a Master’s student at Shandong First Medical University, Rui contributed significantly to pharmacology and clinical pharmacy, focusing on gastrointestinal side effects of GLP-1 receptor agonists and lipid metabolism mechanisms. Their research endeavors led to impactful publications in reputable journals like Frontiers in Endocrinology and Life Sciences. Rui actively collaborated on clinical studies, integrating advanced 3D digitizing technologies into pharmacological applications.

Rui’s experience also includes manuscript submission and presentation at the Clinical Pharmacy Section of the Chinese Medical Association, earning recognition for excellence in research communication. By balancing academic rigors with practical applications, Rui has developed expertise in predicting pharmacological outcomes and optimizing therapeutic strategies. Their professional journey reflects a commitment to bridging academic research with clinical relevance, contributing to the advancement of personalized medicine and innovative healthcare solutions.

🏅 Awards and Recognitions 

Rui Gao’s academic journey is marked by numerous accolades and recognitions. During undergraduate studies at North Minzu University, Rui was celebrated for academic excellence and practical engagement, culminating in the prestigious Certificate of Competence in 3D Digitizing Technology (CAD). In graduate school at Shandong First Medical University, Rui earned scholarships for two consecutive years, reflecting outstanding academic performance and a commitment to research excellence.

Rui’s manuscript presentation at the Clinical Pharmacy Section of the Chinese Medical Association was honored as an outstanding poster presentation, showcasing innovation and impactful contributions to clinical pharmacy. Their publications in leading journals like Frontiers in Endocrinology and Life Sciences further solidify their reputation as a rising researcher in pharmacology. These achievements highlight Rui’s dedication to advancing healthcare and research, making them a promising figure in pharmacological innovation and personalized medicine.

🌍 Research Skills On Pharmacology

Rui Gao’s research skills encompass a robust blend of analytical expertise, technological proficiency, and clinical insight. With a strong focus on pharmacology, Rui has developed predictive models for gastrointestinal adverse reactions caused by GLP-1 receptor agonists, demonstrating an ability to address complex healthcare challenges. Rui’s proficiency in utilizing 3D digitizing technologies enhances the precision and applicability of pharmacological research.

An adept researcher, Rui combines statistical modeling, data analysis, and hands-on experimentation to uncover novel pathways, as evident in their work on lipid metabolism via the ZBTB20-LPL pathway. Rui’s ability to translate findings into impactful publications reflects a keen understanding of scientific communication and collaboration. With experience presenting recognized manuscripts, Rui excels in disseminating research outcomes to diverse audiences. Their interdisciplinary approach and problem-solving mindset make them an invaluable contributor to the advancement of pharmacology and clinical pharmacy.

📖 Publication Top Notes

GCNPMDA: Human microbe-disease association prediction by hierarchical graph convolutional network with layer attention
  • Authors: Wu, C., Lin, B., Zhang, H., Liu, Z.-P., De Marinis, Y.
  • Journal: Biomedical Signal Processing and Control
  • Year: 2025
Multiphase comparative study for WHO/ISUP nuclear grading diagnostic model based on enhanced CT images of clear cell renal cell carcinoma
  • Authors: Lu, C., Xia, Y., Han, J., Gao, R., Jiang, X.
  • Journal: Scientific Reports
  • Year: 2024
  • Citations: 1
A binary-fluid gaseous ejector model under overall modes for anode gas recirculation in solid oxide fuel cell (SOFC) systems
  • Authors: Wang, K., Gao, R., Wang, L.
  • Journal: International Communications in Heat and Mass Transfer
  • Year: 2024
Intelligent tongue diagnosis model for gastrointestinal diseases based on tongue images
  • Authors: Qiao, X., Lu, C., Duan, M., Li, Z., Zuo, X.
  • Journal: Biomedical Signal Processing and Control
  • Year: 2024
LogicGep: Boolean networks inference using symbolic regression from time-series transcriptomic profiling data
  • Authors: Zhang, D., Gao, S., Liu, Z.-P., Gao, R.
  • Journal: Briefings in Bioinformatics
  • Year: 2024
SCSMD: Single Cell Consistent Clustering based on Spectral Matrix Decomposition
  • Authors: Jia, R., Ren, Y.-Z., Li, P.-N., Gao, R., Zhang, Y.-S.
  • Journal: Briefings in Bioinformatics
  • Year: 2024
DCA: An Interpretable Deep Learning Model for Cancer Classification and New Knowledge Discovery Using Attention Mechanism with Discriminate Feature Constraint
  • Authors: Zhang, J., Wu, C., Lu, K., Gao, R.
  • Conference: ACM International Conference Proceeding Series
  • Year: 2024
SpaGRA: Graph augmentation facilitates domain identification for spatially resolved transcriptomics
  • Authors: Sun, X., Zhang, W., Li, W., Yuan, Z., Gao, R.
  • Journal: Journal of Genetics and Genomics
  • Year: 2024 (Article in Press)
MaxCLK: Discovery of cancer driver genes via maximal clique and information entropy of modules
  • Authors: Liu, J., Ma, F., Zhu, Y., Wang, M., Zhang, Y.
  • Journal: Bioinformatics
  • Year: 2023
  • Citations: 1
A Tensor Method Based on Enhanced Tensor Nuclear Norm and Hypergraph Laplacian Regularization for Pan-Cancer Omics Data Analysis
  • Authors: Yu, N., Zhang, Y., Gao, R.
  • Journal: IEEE Journal of Biomedical and Health Informatics
  • Year: 2023
  • Citations: 2